313 related articles for article (PubMed ID: 2990850)
1. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
2. Dopamine inhibits prolactin release when cyclic adenosine 3',5'-monophosphate levels are elevated.
Delbeke D; Scammell JG; Martinez-Campos A; Dannies PS
Endocrinology; 1986 Apr; 118(4):1271-7. PubMed ID: 3004906
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition.
Chuang TT; Caccavelli L; Kordon C; Enjalbert A
Endocrinology; 1993 Feb; 132(2):832-8. PubMed ID: 7678802
[TBL] [Abstract][Full Text] [Related]
5. Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization.
Schettini G; Cronin MJ; MacLeod RM
Endocrinology; 1983 May; 112(5):1801-7. PubMed ID: 6299710
[TBL] [Abstract][Full Text] [Related]
6. Mechanism(s) by which the transient removal of dopamine regulation potentiates the prolactin-releasing action of thyrotropin-releasing hormone.
Martinez de la Escalera G; Weiner RI
Neuroendocrinology; 1988 Mar; 47(3):186-93. PubMed ID: 3129665
[TBL] [Abstract][Full Text] [Related]
7. The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells.
Tam SW; Dannies PS
Endocrinology; 1981 Aug; 109(2):403-8. PubMed ID: 6166464
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glycoprotein hormone free alpha-subunit secretion and intracellular alpha-subunit content in primary pituitary cells.
Holdstock JG; Burrin JM
Endocrinology; 1994 Feb; 134(2):685-94. PubMed ID: 7507833
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
10. Biphasic action of forskolin on growth hormone and prolactin secretion by rat anterior pituitary cells in vitro.
Szabo M; Staib NE; Collins BJ; Cuttler L
Endocrinology; 1990 Oct; 127(4):1811-7. PubMed ID: 1698147
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
12. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway.
Martínez de la Escalera G; Guthrie J; Weiner RI
Neuroendocrinology; 1988 Jan; 47(1):38-45. PubMed ID: 3124014
[TBL] [Abstract][Full Text] [Related]
13. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
Kageyama J
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
[TBL] [Abstract][Full Text] [Related]
14. Effect of dopamine withdrawal on activation of adenylate cyclase and phospholipase C in enriched lactotrophs.
Martinez de la Escalera G; Weiner RI
Endocrinology; 1988 Sep; 123(3):1682-7. PubMed ID: 2456918
[TBL] [Abstract][Full Text] [Related]
15. Roles of intracellular and extracellular calcium in the kinetic profile of adrenocorticotropin secretion by perifused rat anterior pituitary cells. I. Corticotropin-releasing factor stimulation.
Won JG; Orth DN
Endocrinology; 1990 Feb; 126(2):849-57. PubMed ID: 2153529
[TBL] [Abstract][Full Text] [Related]
16. A phorbol ester, phorbol 12-myristate 13-acetate, and a calcium ionophore, A23187, can mimic the luteolytic effect of prostaglandin F2 alpha in isolated rat luteal cells.
Baum MS; Rosberg S
Endocrinology; 1987 Mar; 120(3):1019-26. PubMed ID: 3026783
[TBL] [Abstract][Full Text] [Related]
17. Comparison of patterns of prolactin release in GH4C1 cells and primary pituitary cultures.
Delbeke D; Kojima I; Dannies PS
Mol Cell Endocrinol; 1985 Nov; 43(1):15-22. PubMed ID: 3934015
[TBL] [Abstract][Full Text] [Related]
18. Is calcium or cyclic AMP involved in the inhibitory effect on pituitary hormone secretion of the tripeptide aldehyde proteinase inhibitors?
Makara GB; Szentendrei T; Rappay G
Mol Cell Endocrinol; 1987 Jul; 52(1-2):63-9. PubMed ID: 2442048
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin decreases thyrotropin-releasing hormone-stimulated prolactin release through a mechanism that involves inhibition of inositol phosphate production.
Judd AM; Kubota T; Kuan SI; Jarvis WD; Spangelo BL; Macleod RM
Endocrinology; 1990 Jul; 127(1):191-9. PubMed ID: 2163310
[TBL] [Abstract][Full Text] [Related]
20. Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity.
Ramsdell JS; Tashjian AH
Endocrinology; 1985 Nov; 117(5):2050-60. PubMed ID: 3930223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
